Zankel Todd 4
4 · Raptor Pharmaceutical Corp · Filed Aug 29, 2012
Insider Transaction Report
Form 4
Zankel Todd
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2012-08-27$2.02/sh+287$580→ 669,637 total - Sale
Common Stock
2012-08-27$5.00/sh−287$1,435→ 669,350 total - Exercise/Conversion
Stock options (right to buy)
2012-08-27+287→ 312,563 totalExercise: $2.02From: 2010-03-09Exp: 2020-03-08→ Common Stock (287 underlying)
Footnotes (2)
- [F1]Transaction made pursuant to a Rule 10b5-1 trading plan executed on January 9, 2012.
- [F2]Original option grant vests 6/48ths on March 9, 2010 and 1/48th per month thereafter.